Last checked at 22 Dec 2017 11:27
22 December 2017
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that, further to the vesting of conditional nil-cost options on 20 November 2017 under the Genus Deferred Share Bonus Plan (the 'DSBP') as listed in table A below, the Executive Directors and members of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 19 December 2017, on the London Stock Exchange to offset income tax and social security liabilities due on the exercises, and retained the balance of ordinary shares where applicable.
The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the number of nil-cost options exercised and ordinary shares sold on 19 December 2017.
For further information please contact:
Genus:
Cara Crichton, Deputy Company Secretary Tel: +44 (0)1256 347100
Table A - GELT Deferred Share Bonus Plan Exercises
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a. | Name | 1. Karim Bitar 2. Stephen Wilson 3. Jonathan Lightner | ||||||||
2. | Reason for the notification | |||||||||
a. | Position/status | 1. Chief Executive 2. Group Finance Director 3. Chief Scientific Officer & Head of Genus R&D | ||||||||
b. | Initial notification /Amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a. | Name | Genus plc | ||||||||
b. | LEI | 54930022EOITNKSIGH56 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 10p each
GB0002074580 | ||||||||
b. | Nature of the transaction | 1. Exercise of 4,648 nil-cost options under the DSBP. 2. Exercise of 3,445 nil-cost options under the DSBP. 3. Exercise of 905 nil-cost options under the DSBP. | ||||||||
c. | Price(s) and volume(s) |
| ||||||||
d. | Aggregated information · Aggregated volume · Price
|
| ||||||||
e. | Date of the transaction | 2017-12-19 | ||||||||
f. | Place of the transaction | Outside a trading venue. | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a. a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 10p each
GB0002074580 | ||||||||
b. b. | Nature of the transaction | 1. Sale of 2,192 shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise. 2. Sale of 1,625 shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise. 3. Sale of 905 shares arising from the exercise of nil-cost options under the DSBP partly to offset income tax and social security liabilities due on the exercise. | ||||||||
c. c. | Price(s) and volume(s) |
| ||||||||
d. d. | Aggregated information · Aggregated volume · Price
|
| ||||||||
e. | Date of the transaction | 2017-12-19 | ||||||||
f. | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||||||